v3.26.1
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Preferred Stock
Preferred Stock, Common Stock and Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Common Class A
Common Class A
Common Stock
Common Class B
Common Class B
Common Stock
Preferred stock beginning balance (in shares) at Dec. 31, 2024   4,584              
Common stock beginning balance (in shares) at Dec. 31, 2024             359,602   3
Beginning balance at Dec. 31, 2024 $ 26,486.9   $ 22,406.6 $ 4,185.8 $ (105.5)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net Income 1,981.3     1,981.3          
Other comprehensive income (loss) 150.9       150.9        
Dividends on common stock (912.2)     (912.2)          
Vesting of issued restricted Class A common stock (in shares)             50    
Vesting of issued restricted Class A common stock (8.8)   (8.8)            
Shares issued to Board of Directors (in shares)             11    
Shares issued to Board of Directors 3.0   3.0            
Shares issued under Employee Stock Purchase Plan (in shares)             16    
Shares issued under Employee Stock Purchase Plan 4.2   4.2            
Repurchase of Class A common stock (in shares) [1]             (32)    
Repurchase of Class A common stock [1] (8.2)   (8.2)            
Stock-based compensation 41.9   41.9            
Preferred stock ending balance (in shares) at Jun. 30, 2025   4,584              
Common stock ending balance (in shares) at Jun. 30, 2025             359,647   3
Ending balance at Jun. 30, 2025 27,739.0   22,438.7 5,254.9 45.4        
Preferred stock beginning balance (in shares) at Mar. 31, 2025   4,584              
Common stock beginning balance (in shares) at Mar. 31, 2025             359,646   3
Beginning balance at Mar. 31, 2025 27,030.7   22,419.6 4,685.9 (74.8)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net Income 1,025.1     1,025.1          
Other comprehensive income (loss) 120.2       120.2        
Dividends on common stock (456.1)     (456.1)          
Vesting of issued restricted Class A common stock (in shares)             6    
Vesting of issued restricted Class A common stock (0.6)   (0.6)            
Shares issued to Board of Directors (in shares)             11    
Shares issued to Board of Directors 3.0   3.0            
Shares issued under Employee Stock Purchase Plan (in shares)             16    
Shares issued under Employee Stock Purchase Plan 4.2   4.2            
Repurchase of Class A common stock (in shares) [1]             (32)    
Repurchase of Class A common stock [1] (8.2)   (8.2)            
Stock-based compensation 20.7   20.7            
Preferred stock ending balance (in shares) at Jun. 30, 2025   4,584              
Common stock ending balance (in shares) at Jun. 30, 2025             359,647   3
Ending balance at Jun. 30, 2025 $ 27,739.0   22,438.7 5,254.9 45.4        
Preferred stock beginning balance (in shares) at Dec. 31, 2025 4,584 4,584              
Common stock beginning balance (in shares) at Dec. 31, 2025           358,950 358,950 3 3
Beginning balance at Dec. 31, 2025 $ 28,728.2   22,213.1 6,433.2 81.9        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net Income 2,196.1     2,196.1          
Other comprehensive income (loss) (27.0)       (27.0)        
Dividends on common stock (3,171.8)     (3,171.8)          
Conversion of Series G preferred stock to Class A common stock (in shares)   (4,584)       4,600 4,584    
Vesting of issued restricted Class A common stock (in shares)             96    
Vesting of issued restricted Class A common stock (22.2)   (22.2)            
Shares issued to Board of Directors (in shares)             14    
Shares issued to Board of Directors 3.1   3.1            
Shares issued under Employee Stock Purchase Plan (in shares)             16    
Shares issued under Employee Stock Purchase Plan 4.3   4.3            
Repurchase of Class A common stock (in shares) [2]             (4,385)    
Repurchase of Class A common stock [2] (1,236.9)   (1,236.9)            
Stock-based compensation $ 46.6   46.6            
Preferred stock ending balance (in shares) at Jun. 30, 2026 0 0              
Common stock ending balance (in shares) at Jun. 30, 2026           359,275 359,275 3 3
Ending balance at Jun. 30, 2026 $ 26,520.4   21,008.0 5,457.5 54.9        
Preferred stock beginning balance (in shares) at Mar. 31, 2026   0              
Common stock beginning balance (in shares) at Mar. 31, 2026             361,790   3
Beginning balance at Mar. 31, 2026 26,618.2   21,674.2 4,884.6 59.4        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net Income 1,041.8     1,041.8          
Other comprehensive income (loss) (4.5)       (4.5)        
Dividends on common stock (468.9)     (468.9)          
Vesting of issued restricted Class A common stock (in shares)             1    
Vesting of issued restricted Class A common stock (0.2)   (0.2)            
Shares issued to Board of Directors (in shares)             14    
Shares issued to Board of Directors 3.1   3.1            
Shares issued under Employee Stock Purchase Plan (in shares)             16    
Shares issued under Employee Stock Purchase Plan 4.3   4.3            
Repurchase of Class A common stock (in shares) [2]             (2,546)    
Repurchase of Class A common stock [2] (698.2)   (698.2)            
Stock-based compensation $ 24.8   24.8            
Preferred stock ending balance (in shares) at Jun. 30, 2026 0 0              
Common stock ending balance (in shares) at Jun. 30, 2026           359,275 359,275 3 3
Ending balance at Jun. 30, 2026 $ 26,520.4   $ 21,008.0 $ 5,457.5 $ 54.9        
[1]
(1) In December 2024, the board of directors approved a share repurchase program (the Share Repurchase Program), which authorizes the repurchase of up to $3.0 billion of CME Group Class A common stock at prevailing market prices. During the three and six months ended June 30, 2025, 32,265 shares of outstanding Class A common stock were repurchased at an average price of $253.05 per share for a total of $8.2 million The remaining aggregate amount under the existing Share Repurchase Program is $3.0 billion. Shares are retired upon repurchase and not held as treasury stock.
[2]
(1) In December 2024, the board of directors approved a share repurchase program (the Share Repurchase Program), which authorizes the repurchase of up to $3.0 billion of CME Group Class A common stock at prevailing market prices. During the three and six months ended June 30, 2026, 2,546,284 and 4,384,776 shares of outstanding Class A common stock were repurchased, respectively. The average price was $273.14 per share for a total of $0.7 billion (excluding excise tax) during the second quarter of 2026 and $280.87 per share for a total of $1.2 billion (excluding excise tax) for the first six months of 2026. The remaining aggregate amount under the existing Share Repurchase Program is $1.5 billion. Shares are retired upon repurchase and not held as treasury stock.